000 | 01404 a2200385 4500 | ||
---|---|---|---|
005 | 20250513034801.0 | ||
264 | 0 | _c19950914 | |
008 | 199509s 0 0 eng d | ||
022 | _a0022-2623 | ||
024 | 7 |
_a10.1021/jm00016a009 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKnoerzer, T A | |
245 | 0 | 0 |
_aSynthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors. _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _cAug 1995 |
||
300 |
_a3062-70 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAdenylyl Cyclases _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBinding, Competitive |
650 | 0 | 4 |
_aCorpus Striatum _xenzymology |
650 | 0 | 4 | _aEnzyme Activation |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPhenanthridines _xchemical synthesis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Dopamine _xmetabolism |
650 | 0 | 4 |
_aReceptors, Dopamine D1 _xagonists |
650 | 0 | 4 |
_aReceptors, Dopamine D2 _xagonists |
650 | 0 | 4 | _aStructure-Activity Relationship |
700 | 1 | _aWatts, V J | |
700 | 1 | _aNichols, D E | |
700 | 1 | _aMailman, R B | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 38 _gno. 16 _gp. 3062-70 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00016a009 _zAvailable from publisher's website |
999 |
_c7636305 _d7636305 |